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Abstract
Background: Sepsis is associated with systemic inflammatory responses and induction of coagulation system. Neutrophil
extracellular traps (NETs) constitute an antimicrobial mechanism, recently implicated in thrombosis via platelet entrapment
and aggregation.
Methodology/Principal Findings: In this study, we demonstrate for the first time the localization of thrombogenic tissue
factor (TF) in NETs released by neutrophils derived from patients with gram-negative sepsis and normal neutrophils treated
with either serum from septic patients or inflammatory mediators involved in the pathogenesis of sepsis. Localization of TF
in acidified autophagosomes was observed during this process, as indicated by positive LC3B and LysoTracker staining.
Moreover, phosphatidylinositol 3-kinase inhibition with 3-MA or inhibition of endosomal acidification with bafilomycin A1
hindered the release of TF-bearing NETs. TF present in NETs induced thrombin generation in culture supernatants, which
further resulted in protease activated receptor-1 signaling.
Conclusions/Significance: This study demonstrates the involvement of autophagic machinery in the extracellular delivery
of TF in NETs and the subsequent activation of coagulation cascade, providing evidence for the implication of this process in
coagulopathy and inflammatory response in sepsis.
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Introduction
Systemic activation of coagulation cascade and formation of
thrombi in the microvasculature contribute to organ dysfunction
that characterizes sepsis [1,2]. Several studies in experimental
models indicate that septic inflammatory environment induces the
expression of tissue factor (TF), a trans-membrane protein [2]
which initiates coagulation cascade and results in thrombin
generation. Circulating TF, in the form of TF-bearing micro-
particles or TF expressed in blood cells, is suggested to play
a critical role in this process [1–5]. Additionally, thrombin and
TF/factor VIIa complex signaling through protease activated
receptor-1 (PAR-1) and PAR-2 respectively was implicated in the
induction of inflammation in experimental models of sepsis,
linking coagulation to inflammation [6,7].
Neutrophils have a critical role in launching the first line of host
defense against infection. They are recruited in vast numbers to
the site of microbial invasion, where they engulf and kill pathogens
into phagosomes [8,9]. Moreover, neutrophils release lytic
enzymes for the elimination of extracellular microbes [10].
Recently, another aspect of neutrophil microbicidal activity has
been described; the release of neutrophil extracellular traps (NETs;
[10,11]). NETs are extracellular chromatin structures that entrap
microbes and are composed of nuclear and granule constituents of
neutrophils [10,11]. They are formed after phagocytosis of
pathogens or treatment with inflammatory stimuli [10,11] and
are implicated in the pathogenesis of sepsis [12]. Interestingly, it
was shown that the entrapment of platelets in NETs is associated
with platelet activation and aggregation [13]. Moreover, the
presence of NETs has been recently indentified in thrombi in
a murine model of deep vein thrombosis [14]. Experimental data
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further implicate neutrophil serine proteases in the inactivation of
antithrombin and tissue factor pathway inhibitor which results in
the activation of coagulation [15].
Several lines of evidence support a critical role for autophagy in
the regulation of innate immune responses [16,17]. This process
has been implicated in pathogen elimination and recognition by
intracellular receptors [16,17]. The activation of autophagy in
human neutrophils has been previously linked with phagocytosis
and activation of Toll-like receptors [18]. Moreover, it is reported
that neutrophils from patients with sepsis exhibit vacuolization and
susceptibility toward a necrotic form of cell death, both associated
with autophagy [19]. Additionally, recent data suggest that
autophagy is required in NET release [20,21].
Herein, we describe a novel role of neutrophils in the interface
between inflammation and coagulation. We report for the first
time that TF-bearing NETs are released from neutrophils derived
from patients with gram-negative sepsis, trigger thrombin gener-
ation and subsequent PAR-1 signaling in vitro. Furthermore,
inclusion of TF in autophagosomes was linked with its extracel-
lular delivery in NETs, while inhibition of phosphatidylinositol 3-
kinase (PI3K) signaling or endosomal acidification in neutrophils
abolished NET release and TF trafficking.
Materials and Methods
Human Sepsis Neutrophil and Serum Samples
Peripheral blood neutrophils and serum were collected from
six healthy donors and eight patients with gram-negative sepsis,
hospitalized in First Department of Internal Medicine or
Intensive Care Unit of University Hospital of Alexandroupolis.
Informed written consent has been obtained from every
volunteer or their relatives. The study protocol design was in
accordance with the Declaration of Helsinki and the procedures
have been approved by the local ethics committee (Scientific
Committee of the University Hospital of Alexandroupolis,
Greece). Patient characterization was in accordance to current
clinical practice guidelines [22,23]. The identification of gram-
negative bacteria (Escherichia coli in six patients, Pseudomonas
aeruginosa and Klebsiella pneumonia in the other two) from blood
cultures obtained at the time of blood collection was required
for the final inclusion of the experimental data in the study.
Serum from all patients was obtained at the time of enrollment.
Serum was immediately transferred to ice and isolated by
centrifugation at 4uC at 14006g for 15 min. Serum was stored
at 280uC till used. Neutrophils were isolated from heparinized
blood after double-gradient density centrifugation (Histopaque;
Sigma-Aldrich Co., St Louis, MO, USA) as previously described
[18]. Neutrophil purity (.98%) was assessed by Giemsa staining
and viability (.95%) by Trypan blue staining. Contamination
with platelets was under 1%. The absolute number of
neutrophils was adjusted approximately to 46106 cells/ml in
RPMI. After collection, all patient samples were numbered and
de-identified for patient confidentiality.
Stimulation and Inhibition Studies
Neutrophils were incubated in 5% CO2 at 37uC in a total
volume of 500 ml of RPMI in the presence of 6% serum from
healthy donor. Neutrophils were treated with either opsonized
Escherichia coli (E. coli) at 1/30 neutrophil to bacteria ratio
(Phagoburst, Phagotest; ORPEGEN Pharma, Heidelberg, Ger-
many) or septic serum at a final concentration of 6% in
neutrophil cultures for 3 h. This concentration was the optimal
to stimulate neutrophils and avoid NET degradation. Moreover,
3 hours incubation with sepsis serum demonstrated the highest
percentage of NET releasing neutrophils and thus this time point
was chosen for further experiments. Cells were treated with the
autophagy inhibitor 3-methyladenine (3-MA) (5 mM, Calbio-
chem, San Diego, CA, USA) or bafilomycin A1 (30 nM, Sigma-
Aldrich Co.) 30 min after the addition of bacteria in order to
allow phagocytosis to occur. Moreover, healthy neutrophils were
incubated with a mixture of inflammatory mediators (TNF-a,
1 ng/ml, Sigma-Aldrich; G-CSF, 1 ng/ml, GRANOCYTE-
Aventis, Antony, France; IL-1b, 10 ng/ml, Sigma-Aldrich). An
IgG1 mouse anti-human TF mAb (10 mg/ml; American Diag-
nostica, Greenwich, CT, USA) was used for TF inhibition studies
and an IgG1 anti-CD19 mAb (DAKO, Denmark) as control.
PAR-1 signaling inhibition was performed using FLLRN peptide
(500 mM, Anaspec, Fremont, CA, USA). TLR4 signaling in-
hibition was performed by pre-incubating sepsis serum with
Polymyxin B (10 mg/ml, Santa Cruz, CA, USA) for 30 mins. All
the substances used in this study were endotoxin free, as
determined by a Limulus amebocyte assay (Sigma-Aldrich).
Preparation of Apoptotic Neutrophils
Apoptotic neutrophils were prepared as previously described
[24]. After incubation of neutrophils for 1 h with sepsis serum,
apoptosis was induced by ultraviolet irradiation exposure (245 nm)
for 10 min. Cells remained in RPMI with control serum in 5%
CO2 at 37uC for 2 h. Apoptotic cells indicated more than 80%
Annexin V positive and propidium iodide negative staining as
assessed by flow cytometry (BD Biosciences, FACScan).
Microparticle Depletion
Microparticles were depleted from sepsis serum as previously
described [25]. The collected serum containing microparticles was
centrifuged at 20,0006g for 15 minutes at 4uC to pellet them.
Microparticle-depleted serum (supernatant) was centrifuged again
at 20,0006g for 15 minutes at 4uC in order to eliminate remaining
microparticles. Depletion of microparticles was verified by flow
cytometry as previously described [26].
Immunofluorescence
Sample preparation and visualization by immunofluorescence
microscopy was performed as previously described [21]. Cells were
stained using an anti-myeloperoxidase (MPO)-specific mouse
monoclonal antibody (DAKO), an IgG1 mouse anti-TF mAb
(American Diagnostica, Greenwich, CT, USA), a rabbit anti-
LC3B polyclonal Ab (Sigma-Aldrich Co.) and a mouse anti-high
mobility group box-1 (HMGB1) mAb (Abcam, UK). An IgG1
anti-CD19 mAb (DAKO) was utilized as control. A polyclonal
rabbit anti-mouse Alexa fluor 488 antibody (Invitrogen, Carlsbad,
CA, USA) was utilized as secondary antibody. DNA was
counterstained using DAPI (Sigma-Aldrich). LC3B was stained
with a goat anti-rabbit Alexa fluor 647 antibody (Invitrogen).
LysoTracker (100 nM, Invitrogen) was used for the detection of
acidified endosomes. Cell preparations were visualized in fluores-
cence microscope (Leica DM2000) or confocal microscope
(Spinning Disk Andor Revolution Confocal System, Ireland) in
a PLAPON 606O/TIRFM-SP, NA 1.45 and UPLSAPO
100XO, NA 1.4 objectives (Olympus). The percentage of NET
releasing cells was determined by the evaluation of 200 cells in
a double-blind experimental procedure.
NET Isolation
For protein detection/quantification on NETs, NET proteins
were purified using DNase treatment and precipitated as pre-
viously described [21,27]. NET structure isolation was performed
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by vigorous pippetting and sequential centrifugation, as previously
described [28].
Western Blot Analysis
For TF detection, western blotting was performed in pre-
cipitated samples as previously described [29]. A rabbit anti-
human polyclonal ab (Santa Cruz) was used for TF detection and
a rabbit anti-human polyclonal ab (Trevigen, MD, USA) for
GAPDH. A goat anti-rabbit HRP conjugated polyclonal ab (R&D
Systems, MN, USA) was used as secondary. To evaluate the
expression of TF in NETs, equal amounts of total protein from
each sample were loaded onto the gel to eliminate a potential
discrepancy, due to the absence of a reference protein. For p62/
SQSTM1 detection a mouse anti-human monoclonal ab (Santa
Cruz) was used.
TAT Complex ELISA Assay
Thrombin generation was studied in culture supernatants
from healthy and neutrophils from patients with sepsis, treated
for 3 h. Culture supernatants were collected and centrifuged for
10 min at 3006g. In the case of healthy neutrophils cultured in
vitro in the presence of sepsis serum, culture medium was
removed after 1 h of incubation, cells were washed twice with
1 ml pre-warmed RPMI and incubated for 2 h in fresh culture
medium contained 6% serum from healthy donor. Considering
that sepsis serum contains increased levels of thrombin, this step
ensured the measurement of only NET-dependent thrombin
generation. Afterwards, culture supernatants were collected and
centrifuged at 3006g to remove any cells and at 160006g to
eliminate cellular debris. Isolated NETs structures were added
in RPMI with 6% serum for 30 min. The concentration of
thrombin-antithrombin (TAT) complex was measured according
to manufacturer’s instructions (Assaypro, Winfield, MO, USA).
The minimum detectable dose of the assay was 300 pg/ml.
Platelet Activation Studies
Platelets were isolated from platelet rich plasma obtained from
adult healthy donors as previously described [30], were suspended
in HEPES buffer (200 ml) and incubated with the respective
stimuli for 30 min at 37uC. Afterwards, 100 ml of these
suspensions were stained with either anti-CD62P-PE antibody
(Beckman Coulter, Switzerland) or annexin V-FITC antibody (BD
Biosciences). Platelets were immediately diluted in 500 ml of
HEPES buffer and analyzed by flow cytometry (BD Biosciences,
FACScan). Analyses were performed on 10000 gated platelets in
Cell Quest program (BD Biosciences).
RNA Isolation, cDNA Synthesis and Quantitative Real-
time PCR
RNA isolation, cDNA synthesis and TF qRT-PCR (primers and
conditions) were performed as previously described [29]. Relative
expression levels were determined using the 2DDCT method.
Statistical Analysis
Values are presented as mean 6 SD. Mann-Whitney U-test or
Wilcoxon test was used to assess the statistical significance of
unpaired or paired samples (n$6), respectively. For samples with
n$3 a Student’s t test was used. All statistical analyses were
performed with GraphPad Prism (GraphPad Software, Inc., San
Diego, CA). P values of #.05 were considered significant.
Results
Septic Inflammatory Environment Induces NET Release in
an Autophagy-dependent Manner
The previously described implication of autophagy in NET
release [20,21] prompted us to investigate whether autophagy
inhibition attenuates the release of NETs from neutrophils derived
from patients hospitalized with gram-negative sepsis (sepsis
neutrophils). These cells released NETs after 3 h of incubation,
as demonstrated by co-staining with myeloperoxidase (MPO) and
DAPI (Fig. 1A, Fig. S1). Notably, treatment of sepsis neutrophils
with 3 methyl-adenine (3-MA), a modulator of class III PI3Ks that
inhibits autophagy, or bafilomycin A1, which impairs the
formation of acidified autophagosomes, abrogated NET release
(Fig. 1A, Fig. S1). Moreover, incubation of neutrophils from
control subjects (control neutrophils) with serum from patients
with sepsis resulted in NET release in a time-dependent manner
(Fig. 1B–C, Fig. S1), which was also inhibited by 3-MA or
bafilomycin A1 (Fig. 1B). Treatment of sepsis serum with an LPS
inhibitor (Polymyxin B) did not affected the percentage of NET
releasing cells (Fig. 1B), suggesting that the presence of LPS in
serum from patients with sepsis was not critical for NET
formation.
TF is Localized in NETs Released by Sepsis Neutrophils
The critical role of blood-born TF in the pathogenesis of sepsis
[1,2] motivated the investigation of TF presence in NETs formed
by sepsis neutrophils. TF was identified in NETs released from
these cells (Fig. 2A–B) and control neutrophils treated with sepsis
serum (Fig. 2A–B), as assessed by confocal microscopy and
immunoblotting of NET-derived proteins. As expected, 3-MA
(Fig. 2B) or bafilomycin A1 (Fig. 2A) attenuated NET formation
and the consequent TF externalization.
To further investigate the possible effect of 3-MA or bafilomycin
A1 on intracellular TF levels, sepsis neutrophils or control
neutrophils treated with sepsis serum were incubated in the
presence of 3-MA or bafilomycin A1 for 1 h. This incubation
period was selected to avoid the possible implication of TF
externalization through NETs in the quantification of TF levels.
TF expression levels in sepsis neutrophils (Fig. 2C) and control
neutrophils treated with sepsis serum (Fig. 2D) were not altered in
the presence of 3-MA or bafilomycin A1, suggesting that these
agents do not interfere with the expression of TF in neutrophils.
To address whether de novo TF production contributes to
enhanced TF expression in neutrophils, microparticle-depleted
sepsis serum was acquired by centrifugation (Fig. S2). Treatment
with microparticle-depleted sepsis serum still induced TF expres-
sion, as observed by immunofluorescence microscopy (Fig. 2A),
immunoblotting (Fig. 2E) and flow cytometry analysis (Fig. 2F–G).
Inflammatory Mediators Involved in Sepsis Induce the
Release of TF-bearing NETs
To simulate septic conditions, normal neutrophils were treated
with opsonized E. coli for 3 h. We observed NET formation from
E. coli phagocytosing neutrophils, while the addition of 3-MA or
bafilomycin A1 30 min after the initiation of phagocytosis
completely inhibited NET release (Fig. 1D, Fig. S1). We next
studied the localization of TF in NETs produced after bacterial
phagocytosis. Confocal microscopy (Fig. 3A) and immunoblotting
of NET-derived proteins did not demonstrate TF presence in
NETs released by E. coli phagocytosing neutrophils (Fig. 3A–B).
Moreover, immunoblotting did not show elevated TF protein
levels in these cell lysates (Fig. 3C). To further simulate septic
conditions and considering the reported implication of TNF-a and
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IL-1b in the pathomechanism of sepsis [31], control neutrophils
were stimulated with TNF-a, IL-1b and G-CSF. Even though the
percentage of NET-releasing cells was lower compared to E. coli
phagocytosing neutrophils (Fig. 1C), we observed TF localization
in NETs (Fig. 3A–B), while cellular TF levels were upregulated
(Fig. 3C). To further enhance NET production, neutrophils were
Figure 1. NET formation by sepsis neutrophils and control neutrophils under inflammatory stimuli. Percentage of neutrophils releasing
NETs from (A) sepsis patients (Sepsis PMNs) and (B) neutrophils from control subjects treated with sepsis serum (Sepsis serum) or (D) phagocytosing
opsonized E. coli bacteria (E. coli) alone or in the presence of a mixture of TNF-a, IL-1b and G-CSF (Cyto/E.coli) after 3 h or incubation in the presence
of 3-MA (3MA) or bafilomycin A1 (Bafil) or polymixin B (B) or not. The percentage of NET releasing neutrophils after treatment with sepsis serum at
different time points is shown in (C). Untreated neutrophils from healthy subjects were used as control. Quantification of percentage was performed
on the count of 200 cells per sample. Data are representative of six independent experiments (A, B, D) or three independent experiments (C) and
presented as mean 6 SD. ({P,.05 compared to control, *P,.05).
doi:10.1371/journal.pone.0045427.g001
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treated with the aforementioned factors in the presence of E. coli
bacteria. We detected increased release of NETs decorated with
TF (Fig. 3A–B), while cellular TF protein levels were elevated
(Fig. 3C). Notably, TF mRNA levels were also found elevated in
neutrophils incubated with all the aforementioned inflammatory
stimuli (Fig. 3D), even with E. coli alone, suggesting a role for the
cytokine mixture in the TF post-transcriptional regulation.
Thrombin Generation and PAR Signaling are Triggered
by TF-bearing NETs
We next assessed whether the externalization of TF in NETs is
involved in the activation of coagulation system by sepsis
neutrophils. TAT complex levels were increased in culture
supernatants from sepsis neutrophils (Fig. 4i) and control
neutrophils treated with sepsis serum (Fig. 4ii) or TNF-a, IL-1b
and G-CSF (Fig. 4iii). TF blockade with anti-TF mAb abolished
the aforementioned increase of TAT complex levels (Fig. 4i–iii),
while it had no effect on the production of NETs (data not shown).
On the other hand, E. coli phagocytosis alone was not sufficient for
thrombin generation, despite the formation of NETs (Fig. 4iii).
Moreover, treatment with 3-MA or bafilomycin A1 normalized
TAT levels in culture supernatants from sepsis neutrophils or
control neutrophils treated with sepsis serum or the aforemen-
tioned inflammatory agents (Fig. 4i–iii). Additionally, incubation of
control serum with isolated NET structures demonstrated similar
results regarding thrombin generation. NET structures from
control neutrophils treated with cytokines and E.coli induced
TAT complex levels, while NETs from neutrophil treated only
with E.coli did not (Fig. 4iv). This ability was also TF dependent, as
suggested by the inhibitory effect of anti-TF neutralizing
antibodies (Fig. 4iv).
Platelet activation by thrombin was further investigated, in
order to study its ability for signaling through PAR-1. Platelets
treated with culture supernatant from sepsis neutrophils (Fig. 5i) or
normal neutrophils incubated with sepsis serum (Fig. 5ii) or the
aforementioned cytokines (Fig. 5iii) expressed increased levels of
CD62P and annexin V, as assessed by flow cytometry. Inhibition
of NET release with bafilomycin A1 abolished this effect (Fig. 5i–
iii). TF blockade in neutrophil cultures and PAR-1 inhibition with
FLLRN in culture supernatants also inhibited CD62P and
annexin V expression in platelets (Fig. 5i–iii). Moreover, culture
supernatant from E. coli phagocytosing neutrophils had no effect in
the expression of these markers in platelets (Fig. 5iii).
To compare NET-forming neutrophils with apoptotic ones in
their ability to induce thrombin generation, control neutrophils
were incubated with sepsis serum for 1 h, washed and incubated
for 2 h in normal serum. To induce apoptosis, cells were irradiated
after being treated with sepsis serum. TAT levels in culture
supernatants from irradiated cells were significantly lower
compared with those from non-irradiated cells treated with sepsis
serum and were comparable to neutrophils treated with normal
serum (Fig. 4v). Moreover, culture supernatants from apoptotic
cells did not induce significant elevation of CD62P levels in
platelets (Fig. 5iv).
Localization of TF in LC3 Positive Structures
To further assess whether autophagy is involved in the delivery
of intracellular TF to NETs, the localization of TF and the LC3B
was scrutinized in sepsis neutrophils. After 1 h of incubation, we
observed formation of TF aggregates, which were colocalized with
LC3B-coated structures (Fig. 6A, Fig. S5), as assessed by confocal
microscopy. Inhibition of autophagy by 3-MA attenuated the
aggregation of LC3B and resulted in a more disperse TF staining
(Fig. 6A). Additionally, control neutrophils were treated with sepsis
serum for different time points and the localization of TF and
LC3B were studied. We detected minimal TF levels after 5 min of
stimulation, which were up-regulated at 30 min. TF colocalization
with LC3B-positive structures was observed at 1 h of stimulation
(Fig. 6B, Fig. S3A) and NETs decorated with TF were detected
after 3 h (Fig. 6B). Of interest, TF colocalization with LC3B was
observed in the cytoplasm, and partially in NETs, of NET
releasing cells (Fig. 6B). The same phenomenon was also observed
in control neutrophils simultaneously treated with inflammatory
mediators and E. coli (Fig. S3B). As expected, neutrophils treated
with E. coli alone exhibited increased formation of LC3B positive
structures, while TF levels remained unaltered (Fig. S3B).
Next, we studied whether the engulfment of proteins localized in
NETs in LC3B-coated endosomes is a generalized phenomenon
for NET targeting. Colocalization of high mobility group box-1
(HMGB1) with LC3B-positive structures was observed in
neutrophils treated with sepsis serum following the same pattern
with TF (Fig. 7A, C). On the other hand, we did not detect any
colocalization of MPO with LC3B positive structures under these
conditions (Fig. 7B–C), suggesting that MPO, which is located in
the primary granules, does not follow the same route to reach the
NETs.
Moreover, we investigated whether the observed TF and
HMGB1 containing autophagosomes matured to autophagolyso-
somes. The LC3-coated structures were stained positive with
LysoTracker, suggesting the formation of acidified autophago-
somes (Fig. 8A, Fig. S4A, Fig. S5). As expected, incubation with
bafilomycin A1 attenuated the acidification of autophagosomes
(Fig. 8A).
To verify the induction of autophagic machinery in our model,
p62/SQSTM1 immunoblotting was utilized. We observed degra-
dation of p62/SQSTM1 in control neutrophils treated with sepsis
serum in a time dependent manner, while inhibition of
autophagolysosomal fusion by bafilomycin A1 abolished this
phenomenon (Fig. 8B).
Discussion
In the present study, we provide evidence for the release of TF
through NETs by neutrophils isolated from patients with sepsis.
Moreover, it is demonstrated that an autophagy-based mechanism
Figure 2. Identification of TF in NETs released by sepsis neutrophils. (A) Neutrophils from patients with sepsis (Sepsis PMNs) and control
neutrophils treated with sepsis serum (Sepsis serum) or microparticle-depleted sepsis serum (MP-depleted Sepsis serum) were treated for 3 h and the
localization of TF on NETs was assessed by confocal microscopy (z stack analysis, 0.3 mm per plane). Treatment with bafilomycin A1 (Bafil) inhibited
the release of these structures. One representative out of four independent experiments is shown (DNA labeled with DAPI; blue, anti-TF monoclonal
antibody; green) (original magnification 6006). Scale bar represents 10 mM. (B) TF levels in proteins isolated from NETs released by sepsis neutrophils
or control neutrophils treated with sepsis serum, assessed by immunoblotting. The inhibitory effect of 3-MA in NET release and subsequent presence
of TF in NETs is shown. (C) 3-MA and bafilomycin A1 did not affect TF expression in cell lysates from sepsis PMNs incubated for 1 h and (D) in control
neutrophils treated with sepsis serum for the same period of time. One out of four independent experiments is shown in B–D. (E–F) TF levels in
control neutrophils treated with sepsis serum or microparticle-depleted sepsis serum as demonstrated by western blotting (E) and flow cytometry
analysis (F–G). One out of three independent experiments is shown in E–F. Data in (G) are presented as mean 6 SD. ({P,.05 compared to control).
doi:10.1371/journal.pone.0045427.g002
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is implicated in the extracellular localization of TF in NETs. This
form of TF induces in vitro thrombin generation and subsequent
PAR-1 signaling, suggesting a possible involvement in coagulo-
pathy and inflammatory responses that characterize sepsis.
The activation of coagulation is a critical step in the continuum
of events associated with sepsis. It participates via fibrin deposition
in the prevention of microbial dissemination [32,33]. However,
the activation of coagulation and the formation of thrombi in the
microvasculature may also lead to disseminated intravascular
coagulation (DIC), resulting in multi-organ failure [34,35]. Studies
in both animal and human models suggest the implication of
circulating TF in the progression towards DIC [36,37]. Except
from increased thrombogenicity, TF/thrombin/PARs pathway
participates in the induction and maintenance of systemic
inflammatory response during sepsis [38–40].
Figure 3. TF localization in NETs after in vitro stimulations. (A) Detection of TF in NETs released by control neutrophils treated with TNF-a, IL-
1b and G-CSF (Cyto), or E. coli alone (E. coli) or E. coli in the presence of the aforementioned cytokines (Cyto/E. coli), as assessed by confocal
microscopy (z stack analysis, 0.3 mm per plane). One representative out of four independent experiments is shown (DNA labeled with DAPI; blue, anti-
TF monoclonal antibody; green) (original magnification 6006). Scale bar represents 10 mM. (B) TF levels in NET-isolated proteins and (C) cell lysates,
assessed by immunoblotting. One representative out of four independent experiments is shown. (D) TF mRNA levels in untreated control neutrophils
(control) or treated with TNF-a, IL-1b and G-CSF (Cyto) or E. coli alone (E. coli) or in the presence of the aforementioned cytokines (Cyto/E. coli) or
serum from patients with sepsis (Sepsis serum). Data are representative of four independent experiments and presented as mean 6 SD. ({P,.05).
doi:10.1371/journal.pone.0045427.g003
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Previous studies implicated neutrophils in thrombogenicity.
Neutrophil depletion attenuated thrombus formation in a mouse
model of deep vein thrombosis [41] and plaque formation in
atherosclerosis [42]. Even though de novo TF production [43–45]
or acquisition of microparticle-derived TF [46] is still a matter of
debate, ex vivo and in vivo studies demonstrated that TF in
neutrophils plays a significant role in the induction of both
coagulation and inflammation [43–45]. However, the contribution
of neutrophils in circulating TF levels, responsible for thrombotic
or non-thrombotic disease manifestations, has not been completely
elucidated.
In this study, we describe a novel role for neutrophils in TF-
dependent thrombogenicity. Even though the acquisition of
microparticle-derived TF by neutrophils has been previously
demonstrated [46], in this ex vivo model the inflammatory milieu of
sepsis induced de novo TF production by neutrophils, as indicated
by the effect of microparticle-depleted serum. Moreover, neu-
trophils treated with inflammatory mediators also expressed TF in
mRNA and protein levels. However, E. coli phagocytosis in the
Figure 4. Thrombin generation by NET-forming neutrophils. Thrombin-antithrombin (TAT) complex levels in culture supernatants from sepsis
neutrophils (i) or control neutrophils treated with sepsis serum (ii). Treatment with 3-MA, bafilomycin A1 or anti-TF mAb (a-TF) inhibited this effect.
(iii) TAT complex levels in culture supernatants from control neutrophils treated with E. coli (E.coli), or TNF-a, IL-1b and G-CSF alone (Cyto) or primed
with cytokines before the addition of E. coli (Cyto/E. coli) and the respective inhibition studies using anti-TF mAb. (iv) Induction of TAT complex levels
by isolated NET structures released by neutrophils treated as in (iii). (v) TAT complex levels in culture supernatants from control neutrophils treated
with sepsis serum and subsequently irradiated to undergo apoptosis, or not. Control neutrophils treated with normal serum (control) and anti-CD19
mAb (a-CD19) served as control. Data are representative of four independent experiments and presented as mean 6 SD. (*P,.05, {P,.05 compared
to control, ns = non significant).
doi:10.1371/journal.pone.0045427.g004
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absence of inflammatory mediators was not sufficient for TF
production, despite the observed upregulation of TF mRNA levels.
This finding is in accordance with the previously reported inability
of lipopolysaccharide-treated granulocytes to produce TF [46].
The extracellular delivery of TF in NETs resulted in thrombin
generation in culture supernatants and subsequent signaling
through PAR-1. The key role of TF in NET-dependent activation
of coagulation system was indicated by the inhibitory effect of anti-
TF mAb. This was also supported by the lack of thrombin
generation in culture supernatants from E. coli phagocytosing
neutrophils, which released NETs that were not decorated with
TF. Additionally, the generation of thrombin by isolated NETs
demonstrates that TF localized in NETs is functional. The ability
of NET-forming neutrophils to generate thrombin was further
juxtaposed with that of apoptotic cells. Induction of apoptosis in
neutrophils treated with sepsis serum prevented thrombin
generation in culture supernatants. These findings propose that
the extracellular delivery of TF through NETs plays a key role in
the activation of coagulation system.
The aforementioned contribution of NET generation to
thrombus formation has been previously studied. It has been
shown that platelet-neutrophil interaction in the microvasculature
results not only in NET formation but also in the obstruction of
blood flow and tissue damage [13]. Recent studies demonstrated
a role for NET formation in sepsis-associated vasculopathy, due to
platelet entrapment and activation [14]. Of interest, during the
Figure 5. Platelet activation by NET-forming neutrophils. Expression of CD62P (white bar) and annexin V (grey bar) in (i) sepsis neutrophil, (ii)
control neutrophils treated with sepsis serum or (iii) treated with E. coli (E.coli), or TNF-a, IL-1b and G-CSF alone (Cyto) or primed with cytokines before
the addition of E. coli (Cyto/E. coli). Treatment with bafilomycin A1 or anti-TF mAb in neutrophil cultures or inhibition of PAR-1 signaling in platelets
with FLLRN inhibited this effect. (iv) CD62P expression in control platelets stimulated with supernatants (S/N) from control neutrophils treated with
sepsis serum and subsequently irradiated to undergo apoptosis, or not. Untreated platelets from control subjects (untreated), or incubated with
cytokines (Cyto) or with supernatants from control neutrophils treated with normal serum were used as controls. Expression of CD62P and annexin V
was assessed by flow cytometry and presented as mean fluorescent intensity (MFI). Data are representative of four independent experiments and
presented as mean 6 SD. (*P,.05, {P,.05 compared to control, ns = non significant).
doi:10.1371/journal.pone.0045427.g005
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preparation of this article, a role for NETs in thrombus formation
due to FXII activation has been demonstrated in a mouse model
of deep vein thrombosis [41]. In this mouse model, TF was
observed in NETs, which is in consistency with our study.
We also observed the implication of an autophagy-related
pathway in both NET release and protein trafficking on NETs.
PI3K signaling and endosomal acidification inhibition abrogated
NET release, suggesting the involvement of autophagy, which is in
accordance with previous reports [20,21]. We also demonstrated
the involvement of an autophagy-related mechanism in the
delivery of TF in NETs. TF was accumulated in LC3B-coated
vacuoles and then externalized and localized in NETs. These
vacuoles were also identified as acidified autophagosomes by
staining with LysoTracker. This pathway also participated in the
delivery of HMGB1 to NETs. This nuclear protein, which is
implicated in the pathogenesis of sepsis [47], is translocated to the
cytosol and released through NETs upon neutrophil activation
[21,48]. On the other hand, MPO, a granule protein, did not use
this particular pathway.
These findings suggest that the inclusion of certain proteins into
LC3B-coated endosomes, either integral membrane proteins, like
TF, or cytosolic, such as HMGB1, facilitates their delivery to
NETs. Since no detectable degradation is observed inside the
autophagosomes, at least for the time-scale of our experiments,
a key role for an autophagy-based pathway is proposed as an
unconventional trafficking pathway to NETs. However, proteins
expressed in primary granules, such as MPO, could follow
alternative routes to NETs. An autophagy-based pathway for TF
delivery to NETs is in accordance with recent studies demon-
strating autophagy-based pathways being involved in the secretion
Figure 6. Localization of TF in LC3B positive structures in sepsis neutrophils and control neutrophils treated with sepsis serum. (A)
Sepsis neutrophils were incubated for 1 h and the intracellular distribution of TF and LC3B was assessed by confocal microscopy (z stack analysis,
0.3 mm per plane). Formation of LC3B positive punctuated structures in sepsis neutrophils (Sepsis PMNs) and colocalization of TF with LC3B.
Treatment with 3-MA (Sepsis PMNs/3MA) inhibited the formation of LC3B positive structures and resulted in a disperse TF staining. (B) TF and LC3B
localization in control neutrophils treated with sepsis serum at various time points. (DNA labeled with DAPI; blue, anti-TF mAb; green, anti-LC3B mAb;
red) (original magnification 10006). One out of three independent experiments is shown in A–B. Scale bar represents 5 mM in A–B.
doi:10.1371/journal.pone.0045427.g006
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Figure 7. HMGB1, but not MPO, is colocalized with LC3B in control neutrophils treated with sepsis serum. Control neutrophils were
treated at different time points with sepsis serum and the colocalization of HMGB1 (A) and MPO (B) with LC3B-coated structures was assessed by
confocal microscopy (z stack analysis, 0.3 mm per plane). (DNA labeled with DAPI; blue, anti-LC3B mAb; red, anti-HMGB1; green in A, anti-MPO; green
in B) (original magnification 10006). One out of three independent experiments is shown in A–B. Scale bar represents 5 mM. (C) Percentage of
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of cytosolic proteins. It has been recently reported that the release
of acyl-CoA-binding protein by murine astrocytes [49] and IL-1b
and HMGB1 by bone marrow derived macrophages is based on
an autophagy-dependent secretory pathway through LC3B
positive organelles [50].
In conclusion, our data, in conjunction with previous studies,
provide novel insight into the implication of neutrophil derived TF
in human sepsis thrombogenicity, describing a novel form of
circulating TF. Activated neutrophils, expressing high amounts of
TF, are recruited in vast numbers in the vasculature during sepsis.
The release of TF-bearing NETs at the sites of inflammation may
result in the localized activation of coagulation cascade, leading to
microangiopathy and activation of several cell populations,
including platelets and endothelial cells, through PAR signaling.
Moreover, an autophagy-related pathway emerges as a critical
component in neutrophil function during sepsis by regulating the
translocation of certain neutrophil proteins to NETs, including TF
and HMGB1. Targeting NET formation and/or protein traffick-
ing through autophagy could emerge as a potential strategy in the
treatment of coagulopathy that characterizes sepsis.
Supporting Information
Figure S1 NET formation by septic neutrophils and
control neutrophils treated with inflammatory stimuli.
NET release by untreated neutrophils from patients with sepsis
(Septic PMNs) and control neutrophils treated with septic serum
(Septic serum) or phagocytosing opsonized E. coli bacteria (E. coli)
alone or in the presence of a mixture of TNF-a, IL-1b and G-CSF
(Cyto/E.coli) after 3 h incubation, assessed by immunofluores-
cence microscopy. Inhibition of NET formation in neutrophils
treated with 3-MA (3MA) or bafilomycin A1 (Bafil). Untreated
neutrophils indicating colocalization of LC3B with TF, HMGB1 or MPO. Quantification of percentage was performed on the count of 50 cells per
sample. Data are representative of three independent experiments and presented as mean 6 SD. ({ P,.05 compared to control, *P,.05).
doi:10.1371/journal.pone.0045427.g007
Figure 8. Formation of autophagolysosomes in control neutrophils treated with sepsis serum and degradation of p62/SQSTM1. A.
Control neutrophils were treated at different time points with sepsis serum and the localization of TF in autophagolysosomes was assessed.
Autophagolysosomes were visualized as LC3B and LysoTracker double positive structures and were assessed by confocal microscopy (z stack analysis,
0.3 mm per plane). (DNA labeled with DAPI; blue, anti-LC3B mAb; white, anti-TF; green, LysoTracker; red) (original magnification 10006). Scale bar
represents 5 mM. B. p62/SQSTM1 protein levels in control neutrophils treated with sepsis serum at different time points. Treatment with bafilomycin
A1 inhibited p62/SQSTM1 degradation. One out of three independent experiments is shown in A–B.
doi:10.1371/journal.pone.0045427.g008
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neutrophils from healthy subjects were used as control. One
representative out of six independent experiments is shown (DNA
labeled with DAPI; blue, anti-MPO monoclonal antibody; green)
(original magnification 4006). Scale bar represents 30 mM.
(TIF)
Figure S2 Microparticle depletion from sepsis serum.
FACS analysis of sepsis serum and microparticle depleted sepsis
serum by centrifugation as indicated by Annexin V-FITC staining.
Isotype: sepsis serum stained with mouse IgG1-FITC. One out of
three independent experiments is shown.
(TIF)
Figure S3 Localization of TF or MPO in LC3B-coated
structures in control neutrophils treated with inflam-
matory stimuli. (A) Single plane analysis of TF or MPO
localization in LC3B-coated structures in control neutrophils
treated with septic serum for 60 mins. (DNA labeled with DAPI;
blue, anti-TF monoclonal antibody or anti-MPO monoclonal
antibody; green, anti-LC3B mAb; red) (original magnification
10006). Arrows indicate LC3-coated autophagosomes. Scale bar
represents 5 mM. (B) TF and LC3B localization in control
neutrophils treated with inflammatory cytokines and/or E. coli at
various time points. Colocalization of TF with LC3B is detected
both intracellularly and in NETs only in neutrophils treated with
both cytokines and E. coli. Neutrophils treated with E. coli alone do
not express TF. (DNA labeled with DAPI; blue, anti-TF mAb;
green, anti-LC3B mAb; red) (original magnification 10006). One
out of three independent experiments is shown. Scale bar
represents 5 mM.
(TIF)
Figure S4 Localization of HMGB1 or MPO in late
autophagosomes in control neutrophils treated septic
serum. Control neutrophils were treated at different time points
with septic serum and the colocalization of HMGB1 (A) and MPO
(B) with autophagolysosomes was assessed. Autophagolysosomes
were visualized by confocal microscopy as LC3B and LysoTracker
double positive structures (z stack analysis, 0.3 mm per plane).
(DNA labeled with DAPI; blue, anti-LC3B mAb; white, anti-MPO
or anti-HMGB1 mAB; green, LysoTracker; red) (original
magnification 10006). One out of three independent experiments
is shown. Scale bar represents 5 mM.
(TIF)
Figure S5 Comparison of z-stack with single plane
analysis in colocalization studies. z-axies and Single Plane
analysis of TF and LC3 in sepsis PMNs or control PMNs treated
with sepsis serum. Scale bar represents 5 mM.
(TIF)
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